Osteoporosis caused by mutations in PLS3: Clinical and bone tissue characteristics

Journal of Bone and Mineral Research

Volumn 29, Issue 8, 2014, Pages 1805-1814

  Fahiminiya, Somayyeh ^a   Majewski, Jacek ^a   Al Jallad, Hadil ^b   Moffatt, Pierre ^b   Mort, John ^b   Glorieux, Francis H ^b   Roschger, Paul ^c   Klaushofer, Klaus ^c   Rauch, Frank ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Bone Brittleness; Mineralization; Osteogenesis Imperfecta; Plastin 3; Quantitative Backscattered Electron Imaging

Indexed keywords

ALENDRONIC ACID; BINDING PROTEIN; COLLAGEN TYPE 1; PLASTIN 3 PROTEIN; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; MEMBRANE PROTEIN; PLASTIN;

ANTHROPOMETRY; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; BONE FRAGILITY; BONE TISSUE; CASE REPORT; CLINICAL FEATURE; COMPRESSION FRACTURE; COMPUTER ASSISTED TOMOGRAPHY; FRACTURE; GENE MUTATION; HUMAN; ILIAC BONE; LUMBAR SPINE; MALE; MORPHOMETRICS; OSSIFICATION; OSTEOCLAST; OSTEOID; OSTEOPOROSIS; TRABECULAR BONE; TREATMENT DURATION; ADULT; CHILD; COMPLICATION; FEMALE; FRACTURES, BONE; GENETICS; MUTATION; PATHOLOGY;

ADULT; BONE DENSITY; CHILD; FEMALE; FRACTURES, BONE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICROFILAMENT PROTEINS; MUTATION; OSTEOPOROSIS;

EID: 84904599955     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2208     Document Type: Article

References (47)

1. Bishop N, Glorieux FH., Juvenile osteoporosis. In:, Rosen CJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 8th ed. Washington, DC: American Society for Bone and Mineral Research; 2013. p. 468-72.
2. Forlino A, Cabral WA, Barnes AM, Marini JC., New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol. 2011; 7: 540-57.
3. Dent CE, Friedman M., Idiopathic juvenile osteoporosis. Q J Med. 1965; 34: 177-210.
4. Ben Amor M, Rauch F, Monti E, Antoniazzi F., Osteogenesis imperfecta. Pediatr Endocrinol Rev. 2013; 10 (Suppl 2): 397-405.
5. Rauch F, Lalic L, Roughley P, Glorieux FH., Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta. J Bone Miner Res. 2010; 25: 1367-74.
6. Rauch F, Lalic L, Roughley P, Glorieux FH., Genotype-phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I. Eur J Hum Genet. 2010; 18: 642-7.
7. Marini JC, Blissett AR., New genes in bone development: what's new in osteogenesis imperfecta. J Clin Endocrinol Metab. 2013; 98: 3095-103.
8. van Dijk FS, Zillikens MC, Micha D, et al. PLS3 mutations in X-linked osteoporosis with fractures. N Engl J Med. 2013; 369: 1529-36.
9. Delanote V, Vandekerckhove J, Gettemans J., Plastins: versatile modulators of actin organization in (patho)physiological cellular processes. Acta Pharmacol Sin. 2005; 26: 769-79.
10. Shinomiya H., Plastin family of actin-bundling proteins: its functions in leukocytes, neurons, intestines, and cancer. Int J Cell Biol. 2012; 2012: 213492.
11. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002; 109: 45-60.
12. D'Amour P, Labelle F, Lecavalier L, Plourde V, Harvey D., Influence of serum Ca concentration on circulating molecular forms of PTH in three species. Am J Physiol. 1986; 251: E680-7.
13. Bollen AM, Eyre DR,. Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides. Bone. 1994; 15: 31-4.
14. Glastre C, Braillon P, David L, Cochat P, Meunier PJ, Delmas PD., Measurement of bone mineral content of the lumbar spine by dual energy X-ray absorptiometry in normal children: correlations with growth parameters. J Clin Endocrinol Metab. 1990; 70: 1330-3.
15. Southard RN, Morris JD, Mahan JD, et al. Bone mass in healthy children: measurement with quantitative DXA. Radiology. 1991; 179: 735-8.
16. Rauch F, Schoenau E., Peripheral quantitative computed tomography of the distal radius in young subjects-new reference data and interpretation of results. J Musculoskelet Neuronal Interact. 2005; 5: 119-26.
17. Rauch F, Schoenau E., Peripheral quantitative computed tomography of the proximal radius in young subjects-new reference data and interpretation of results. J Musculoskelet Neuronal Interact. 2008; 8: 217-26.
18. Neu CM, Rauch F, Rittweger J, Manz F, Schoenau E., Influence of puberty on muscle development at the forearm. Am J Physiol Endocrinol Metab. 2002; 283: E103-7.
19. Schoenau E, Neu CM, Beck B, Manz F, Rauch F., Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unit. J Bone Miner Res. 2002; 17: 1095-101.
20. Glorieux FH, Travers R, Taylor A, et al. Normative data for iliac bone histomorphometry in growing children. Bone. 2000; 26: 103-9.
21. Kamioka H, Sugawara Y, Honjo T, Yamashiro T, Takano-Yamamoto T., Terminal differentiation of osteoblasts to osteocytes is accompanied by dramatic changes in the distribution of actin-binding proteins. J Bone Miner Res. 2004; 19: 471-8.
22. Roschger P, Fratzl-Zelman N, Misof BM, Glorieux FH, Klaushofer K, Rauch F., Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations. Calcif Tissue Int. 2008; 82: 263-70.
23. Roschger P, Fratzl P, Eschberger J, Klaushofer K., Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone. 1998; 23: 319-26.
24. Roschger P, Paschalis EP, Fratzl P, Klaushofer K., Bone mineralization density distribution in health and disease. Bone. 2008; 42: 456-66.
25. Fratzl-Zelman N, Roschger P, Misof BM, et al. Normative data on mineralization density distribution in iliac bone biopsies of children, adolescents and young adults. Bone. 2009; 44: 1043-8.
26. Fahiminiya S, Majewski J, Roughley P, Roschger P, Klaushofer K, Rauch F., Whole-exome sequencing reveals a heterozygous LRP5 mutation in a 6-year-old boy with vertebral compression fractures and low trabecular bone density. Bone. 2013; 57: 41-6.
27. Li H, Durbin R., Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25: 1754-60.
28. Li H, Handsaker B, Wysoker A, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25: 2078-9.
29. Wang K, Li M, Hakonarson H., ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010; 38: e164.
30. Galkin VE, Orlova A, Cherepanova O, Lebart MC, Egelman EH., High-resolution cryo-EM structure of the F-actin-fimbrin/plastin ABD2 complex. Proc Natl Acad Sci U S A. 2008; 105: 1494-8.
31. Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25: 1605-12.
32. Asharani PV, Keupp K, Semler O, et al. Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish. Am J Hum Genet. 2012; 90: 661-74.
33. Martinez-Glez V, Valencia M, Caparros-Martin JA, et al. Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum Mutat. 2012; 33: 343-50.
34. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7: 248-9.
35. Kumar P, Henikoff S., Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009; 4: 1073-81.
36. Schwarz JM, Rodelsperger C, Schuelke M, Seelow D., MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010; 7: 575-6.
37. Rauch F, Plotkin H, Dimeglio L, et al. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions. J Clin Densitom. 2008; 11: 22-8.
38. Babb SG, Matsudaira P, Sato M, Correia I, Lim SS., Fimbrin in podosomes of monocyte-derived osteoclasts. Cell Motil Cytoskeleton. 1997; 37: 308-25.
39. Rauch F, Travers R, Parfitt AM, Glorieux FH., Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone. 2000; 26: 581-9.
40. Kim JM, Kim J, Kim YH, et al. Comparative secretome analysis of human bone marrow-derived mesenchymal stem cells during osteogenesis. J Cell Physiol. 2013; 228: 216-24.
41. Thouverey C, Malinowska A, Balcerzak M, et al. Proteomic characterization of biogenesis and functions of matrix vesicles released from mineralizing human osteoblast-like cells. J Proteomics. 2011; 74: 1123-34.
42. Oprea GE, Krober S, McWhorter ML, et al. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science. 2008; 320: 524-7.
43. Ackermann B, Krober S, Torres-Benito L, et al. Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality. Hum Mol Genet. 2013; 22: 1328-47.
44. Sawakami K, Robling AG, Ai M, et al. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J Biol Chem. 2006; 281: 23698-711.
45. Rauch F, Plotkin H, Zeitlin L, Glorieux FH., Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy. J Bone Miner Res. 2003; 18: 610-4.
46. Rauch F, Neu C, Manz F, Schoenau E., The development of metaphyseal cortex - implications for distal radius fractures during growth. J Bone Miner Res. 2001; 16: 1547-55.
47. Rauch F, Cornibert S, Cheung M, Glorieux FH., Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta. Bone. 2007; 40: 821-7.